Check Out Recent News & Announcements Below

Choose from the following categories or just search.

    Posts by Tag

    See all
    MIPS final rule 2021

    MIPS 2021: MVPs and QCDR Changes Coming

    Last week, CMS released the final rule for the changes to the Merit-Based Incentive Payment System (MIPS). While there are only minor changes to the program in 2020, bigger changes are expected in 2021. Here are two of the big takeaways from the final rule.

    MIPS Value Pathways (MVPs)

    CMS intends to move toward what they say would be a more streamlined MIPS program. To fulfill upon this vision, the agency intends to reduce reported complexities with data submission and confusion surrounding measure selection with a new framework they are calling MIPS Value Pathways (MVPs).

    In the MVP framework, CMS intends to work with stakeholders to create sets of measure options that they say would be more relevant to clinician scope of practice and meaningful to patient care. MIPS-eligible clinicians would no longer choose their measures from a single inventory, but would instead fulfill pre-defined measures and activities connected to a specialty or condition.

    At this time, CMS has not determined whether participation in MVPs in 2021 would be optional or mandatory.

    Many aspects of the MVP framework are still unclear, and we will be following and providing updates as they are released by CMS. Subscribe to our MIPS newsletter to keep up to date on the MVP discussion.

    Qualified Clinical Data Registries (QCDR)

    In the current QPP landscape, QCDRs are not required to support multiple MIPS performance categories. However, beginning in performance year 2021, QCDRs will be required to submit data for the Quality, Improvement Activities, and Promoting Interoperability categories for the entire performance year and applicable submission period.

    CMS is looking to achieve alignment of similar measures across QCDRs, with an emphasis on outcome measures. Starting in 2021, this would require full measure development and testing at the clinician level prior to the time of self-nomination. Additionally, CMS would implement a set of formalized guidelines for QCDR measure rejections.

    You can read more about these proposed changes in the Quality Payment Program final rule.'

     

    Follow us on LinkedIn

    February 3rd, 2021 Categories: improvement activities, quality category, QCDR, QPP, macra, CMS, Improvement, MIPS, Quality, quality payment program